Skip to main content

Understanding How Fc-Modification Transforms a Pathogenic Heparin-Induced Thrombocytopenia (HIT)-like Monoclonal Antibody into a Novel Treatment for Sepsis.

Publication ,  Journal Article
Gollomp, K; Sarkar, A; Arepally, G; Cines, DB; Kowalska, MA; Rauova, L; Poncz, M
Published in: Blood
November 13, 2019

DISCLOSURES: Arepally: Biokit: Patents & Royalties; Apotex Pharmaceuticals: Consultancy; Veralox Therapeutics: Membership on an entity's Board of Directors or advisory committees.

Duke Scholars

Published In

Blood

DOI

EISSN

1528-0020

Publication Date

November 13, 2019

Volume

134

Issue

Supplement_1

Start / End Page

10

Location

United States

Related Subject Headings

  • Immunology
  • 1114 Paediatrics and Reproductive Medicine
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Gollomp, K., Sarkar, A., Arepally, G., Cines, D. B., Kowalska, M. A., Rauova, L., & Poncz, M. (2019). Understanding How Fc-Modification Transforms a Pathogenic Heparin-Induced Thrombocytopenia (HIT)-like Monoclonal Antibody into a Novel Treatment for Sepsis. Blood, 134(Supplement_1), 10. https://doi.org/10.1182/blood-2019-123132
Gollomp, Kandace, Amrita Sarkar, Gowthami Arepally, Douglas B. Cines, M Anna Kowalska, Lubica Rauova, and Mortimer Poncz. “Understanding How Fc-Modification Transforms a Pathogenic Heparin-Induced Thrombocytopenia (HIT)-like Monoclonal Antibody into a Novel Treatment for Sepsis.Blood 134, no. Supplement_1 (November 13, 2019): 10. https://doi.org/10.1182/blood-2019-123132.
Gollomp K, Sarkar A, Arepally G, Cines DB, Kowalska MA, Rauova L, et al. Understanding How Fc-Modification Transforms a Pathogenic Heparin-Induced Thrombocytopenia (HIT)-like Monoclonal Antibody into a Novel Treatment for Sepsis. Blood. 2019 Nov 13;134(Supplement_1):10.
Gollomp, Kandace, et al. “Understanding How Fc-Modification Transforms a Pathogenic Heparin-Induced Thrombocytopenia (HIT)-like Monoclonal Antibody into a Novel Treatment for Sepsis.Blood, vol. 134, no. Supplement_1, Nov. 2019, p. 10. Pubmed, doi:10.1182/blood-2019-123132.
Gollomp K, Sarkar A, Arepally G, Cines DB, Kowalska MA, Rauova L, Poncz M. Understanding How Fc-Modification Transforms a Pathogenic Heparin-Induced Thrombocytopenia (HIT)-like Monoclonal Antibody into a Novel Treatment for Sepsis. Blood. 2019 Nov 13;134(Supplement_1):10.

Published In

Blood

DOI

EISSN

1528-0020

Publication Date

November 13, 2019

Volume

134

Issue

Supplement_1

Start / End Page

10

Location

United States

Related Subject Headings

  • Immunology
  • 1114 Paediatrics and Reproductive Medicine
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology